Compared with the non-tumor-bearing group, the percentages of CD3+ T lymphocytes, CD4+ T lymphocytes and the CD4+/CD8+ ratio of tumor-bearing rats were significantly lower before operation (P<0.05) (Fig. 3). The gene discussed is CD8A; the disease is neoplasm.